ES8603423A1 - Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina - Google Patents

Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina

Info

Publication number
ES8603423A1
ES8603423A1 ES542817A ES542817A ES8603423A1 ES 8603423 A1 ES8603423 A1 ES 8603423A1 ES 542817 A ES542817 A ES 542817A ES 542817 A ES542817 A ES 542817A ES 8603423 A1 ES8603423 A1 ES 8603423A1
Authority
ES
Spain
Prior art keywords
ethoxycarbonylamino
benzylamino
fluoro
pyridine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542817A
Other languages
English (en)
Other versions
ES542817A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of ES8603423A1 publication Critical patent/ES8603423A1/es
Publication of ES542817A0 publication Critical patent/ES542817A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10—Polyhydroxy carboxylic acids
    • C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE GLUCONATO DE 2-AMINO-3-ETOXICARBONILAMINO-6-(P-FLUOROBENCILAMINO)-PIRIDINA, DE FORMULA (I). CONSISTE EN LA REACCION DE 2-AMINO-3-ETOXICARBONIL-AMINO-6-(P-FLUOROBENCILAMINO)-PIRIDINA, CON O SIN DISOLVENTE, CON ACIDO GLUCONICO, O CON 8-LACTONA DEL ACIDO GLUCONICO EN UNA MEZCLA DE AGUA Y UN DISOLVENTE ORGANICO. LA REACCION SE LLEVA A CABO EN AUSENCIA DE DISOLVENTES O EN UN DISOLVENTE ORGANICO, TAL COMO ALCOHOL INFERIOR, CETONA INFERIOR O POLIOLES, A UNA TEMPERATURA ENTRE 20JC Y 140JC. ESTE COMPUESTO TIENE APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD COMO ANTIFLOGISTICO Y ANALGESICO.
ES542817A 1984-05-05 1985-05-03 Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina Granted ES542817A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (2)

Publication Number Publication Date
ES8603423A1 true ES8603423A1 (es) 1985-12-16
ES542817A0 ES542817A0 (es) 1985-12-16

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542817A Granted ES542817A0 (es) 1984-05-05 1985-05-03 Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina

Country Status (25)

Country Link
US (1) US4673666A (es)
EP (1) EP0160865B1 (es)
JP (1) JPS60239469A (es)
KR (1) KR850008678A (es)
AT (1) ATE33638T1 (es)
AU (1) AU4194385A (es)
BG (1) BG44537A3 (es)
CA (1) CA1263398A (es)
CS (1) CS248743B2 (es)
DD (1) DD236927A5 (es)
DE (2) DE3416609A1 (es)
DK (1) DK157016C (es)
ES (1) ES542817A0 (es)
FI (1) FI80443C (es)
GR (1) GR851065B (es)
HU (1) HU193753B (es)
IE (1) IE57766B1 (es)
IL (1) IL75086A (es)
MC (1) MC1651A1 (es)
NO (1) NO851772L (es)
PL (1) PL253202A1 (es)
PT (1) PT80386B (es)
SU (1) SU1398772A3 (es)
YU (1) YU71785A (es)
ZA (1) ZA853351B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2009152142A1 (en) * 2008-06-09 2009-12-17 Awd. Pharma Gmbh & Co. Kg Sulfonate salts of flupirtine
US8183267B2 (en) 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"

Also Published As

Publication number Publication date
IL75086A0 (en) 1985-09-29
CS248743B2 (en) 1987-02-12
ATE33638T1 (de) 1988-05-15
ES542817A0 (es) 1985-12-16
CA1263398A (en) 1989-11-28
SU1398772A3 (ru) 1988-05-23
JPS60239469A (ja) 1985-11-28
EP0160865A2 (de) 1985-11-13
FI80443B (fi) 1990-02-28
DK198785A (da) 1985-11-06
DK157016C (da) 1990-03-26
GR851065B (es) 1985-11-25
IE851117L (en) 1985-11-05
DK157016B (da) 1989-10-30
FI80443C (fi) 1990-06-11
PL253202A1 (en) 1986-07-15
DD236927A5 (de) 1986-06-25
IE57766B1 (en) 1993-03-24
MC1651A1 (fr) 1986-04-07
IL75086A (en) 1988-03-31
DE3416609A1 (de) 1985-11-07
ZA853351B (en) 1985-12-24
HUT37758A (en) 1986-02-28
DK198785D0 (da) 1985-05-02
DE3562242D1 (en) 1988-05-26
PT80386A (de) 1985-06-01
HU193753B (en) 1987-11-30
JPH0144185B2 (es) 1989-09-26
AU4194385A (en) 1985-11-07
FI851752A0 (fi) 1985-05-03
BG44537A3 (en) 1988-12-15
KR850008678A (ko) 1985-12-21
YU71785A (en) 1988-02-29
FI851752L (fi) 1985-11-06
US4673666A (en) 1987-06-16
EP0160865A3 (en) 1986-03-12
NO851772L (no) 1985-11-06
PT80386B (de) 1987-04-16
EP0160865B1 (de) 1988-04-20

Similar Documents

Publication Publication Date Title
ES8603423A1 (es) Procedimiento para preparar gluconato de 2-amino-3-etoxicar-bonil-amino-6-(p-fluoro-bencilamino)-piridina
MY101791A (en) New benzimidazole derivatives
HUT46221A (en) Process for production of medical compositions containing alphusosine
HUT45895A (en) Process for production of serotomin antagonic compounds and medical preparatives containing such compositions
ES8406477A1 (es) Procedimiento para la preparacion de b-carbolinas
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
HUT44794A (en) Process for production of calcitonine-derivatives and medical preparatives containing such compounds
MY102277A (en) Quinoline compounds
ES8304969A1 (es) Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas.
HUT45979A (en) Process for production of 5-phenil-2-oxasole-derivatives and medical compositions containing such compounds
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES2001775A6 (es) Un procedimiento para preparar derivados de 2-cianofenetilamina
SE8405588D0 (sv) New compounds
JPS52131513A (en) Neopentyl alcoholesters and cosmetics containing same
ES8700936A1 (es) Un metodo de producir una composicion farmaceutica estabili-zada
NZ212658A (en) Phenylnaphthyridine derivatives and pharmaceutical compositions
GB2081708B (en) Novel derivatives of (1-benzyl-1h-indazol-3-yl) oxyacetic acid and pharmaceutical composition containing it
IL54949A (en) Pharmaceutical compositions containing 4-hydroxy-2-oxoquinoline-3-carboxylic acid derivatives and novel compounds of this type
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
MY103446A (en) New alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same.
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
IL74264A0 (en) Preparation of calciferol derivatives,certain such novel compounds and pharmaceutical compositions containing them
ES8606852A1 (es) Procedimiento de obtencion de fenilbenzoilureas
DE3663664D1 (en) Compounds having antiplatelet aggregation activity, a process for the preparation thereof and pharmaceutical compositions containing them
HUT46886A (en) Process for production of derivatives of 2-amin-propion-acid and medical compositions containing them

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20051011